BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28054310)

  • 1. Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids.
    Gualtierotti R; Guarnaccia L; Beretta M; Navone SE; Campanella R; Riboni L; Rampini P; Marfia G
    Adv Ther; 2017 Feb; 34(2):396-420. PubMed ID: 28054310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sphingolipids in neuroinflammation: a potential target for diagnosis and therapy.
    Lee JY; Jin HK; Bae JS
    BMB Rep; 2020 Jan; 53(1):28-34. PubMed ID: 31818364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex contribution of chemokines to neuroinflammation: switching from beneficial to detrimental effects.
    Le Thuc O; Blondeau N; Nahon JL; Rovère C
    Ann N Y Acad Sci; 2015 Sep; 1351():127-40. PubMed ID: 26251227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines in immune-mediated inflammation of the central nervous system.
    Ransohoff RM; Glabinski A; Tani M
    Cytokine Growth Factor Rev; 1996 Jun; 7(1):35-46. PubMed ID: 8864353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemokines and their receptors in the central nervous system.
    Bajetto A; Bonavia R; Barbero S; Florio T; Schettini G
    Front Neuroendocrinol; 2001 Jul; 22(3):147-84. PubMed ID: 11456467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details.
    Rebenko-Moll NM; Liu L; Cardona A; Ransohoff RM
    Curr Opin Immunol; 2006 Dec; 18(6):683-9. PubMed ID: 17010588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration.
    Kempuraj D; Thangavel R; Selvakumar GP; Zaheer S; Ahmed ME; Raikwar SP; Zahoor H; Saeed D; Natteru PA; Iyer S; Zaheer A
    Front Cell Neurosci; 2017; 11():216. PubMed ID: 28790893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroinflamm-aging and neurodegenerative diseases: an overview.
    Pizza V; Agresta A; D'Acunto CW; Festa M; Capasso A
    CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):621-34. PubMed ID: 21631404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoplasmic reticulum stress and inflammation in the central nervous system.
    Sprenkle NT; Sims SG; Sánchez CL; Meares GP
    Mol Neurodegener; 2017 May; 12(1):42. PubMed ID: 28545479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.
    Pranzatelli MR
    Front Immunol; 2018; 9():557. PubMed ID: 29670611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines and chemokines as mediators of protection and injury in the central nervous system assessed in transgenic mice.
    Wang J; Asensio VC; Campbell IL
    Curr Top Microbiol Immunol; 2002; 265():23-48. PubMed ID: 12014193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection.
    Cacabelos R; Torrellas C; Fernández-Novoa L; Aliev G
    Curr Pharm Des; 2016; 22(7):819-48. PubMed ID: 26648474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroinflammation and Infection: Molecular Mechanisms Associated with Dysfunction of Neurovascular Unit.
    Tohidpour A; Morgun AV; Boitsova EB; Malinovskaya NA; Martynova GP; Khilazheva ED; Kopylevich NV; Gertsog GE; Salmina AB
    Front Cell Infect Microbiol; 2017; 7():276. PubMed ID: 28676848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive Lipids and Chronic Inflammation: Managing the Fire Within.
    Chiurchiù V; Leuti A; Maccarrone M
    Front Immunol; 2018; 9():38. PubMed ID: 29434586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases.
    González H; Pacheco R
    J Neuroinflammation; 2014 Dec; 11():201. PubMed ID: 25441979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of autoimmune CNS inflammation by astrocytes.
    Rothhammer V; Quintana FJ
    Semin Immunopathol; 2015 Nov; 37(6):625-38. PubMed ID: 26223505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathological pain and the neuroimmune interface.
    Grace PM; Hutchinson MR; Maier SF; Watkins LR
    Nat Rev Immunol; 2014 Apr; 14(4):217-31. PubMed ID: 24577438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases.
    Cartier L; Hartley O; Dubois-Dauphin M; Krause KH
    Brain Res Brain Res Rev; 2005 Feb; 48(1):16-42. PubMed ID: 15708626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between sphingolipids-mediated neuroinflammation and alcohol use disorder.
    Cui X; Li J; Wang C; Ishaq HM; Zhang R; Yang F
    Pharmacol Biochem Behav; 2024 Feb; 235():173695. PubMed ID: 38128765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis.
    Azizi G; Khannazer N; Mirshafiey A
    Am J Alzheimers Dis Other Demen; 2014 Aug; 29(5):415-25. PubMed ID: 24408754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.